Fundz

Moderna Therapeutics, Inc. reported raising $451 Million in an initial SEC Form D filing, from an offering of $600 Million

PUBLIC · MRNAAug 24, 2016$451.4M of $600M raised

Amount Raised

$451 Million

$451 Million sold, per SEC Form D (first sale Aug 24, 2016)

Round Type

Venture

CambridgeBiotechnologyHealth CareBiopharma

Quick answer

Moderna raised $451 Million in a funding round, dated August 24, 2016. Moderna is based in Cambridge, Massachusetts, United States.

How much did Moderna raise?
Moderna raised $451 Million in a funding round on August 24, 2016.
What does Moderna do?
Moderna is a leader in the creation of the field of mRNA medicine.
Where is Moderna based and how big is it?
Moderna is based in Cambridge, Massachusetts, United States. Fundz records about 5,800 employees.
Who are the decision-makers at Moderna?
Fundz holds 2 contacts at Moderna, including the Chief Procurement Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biopharma and Biotechnology around the same time

Companies in the same sectors as Moderna that raised within 45 days of this round, from Fundz verified event records.

  • Fate Therapeutics raised $10M on August 19, 2016.
  • AEON Biopharma raised $5.5M on August 10, 2016.
  • Oragenics raised $4.7M (Seed) on July 13, 2016.
  • AcuFocus, Inc. raised $75M on October 5, 2016.
  • Aura Biosciences, Inc. raised $1.8M (Seed) on September 30, 2016.
  • Biolinq raised $59M on September 28, 2016.

Who to call at Moderna, and when

A new round usually means Moderna is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Moderna raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Moderna, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Moderna. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Moderna

Location

325 Binney Street

Cambridge, Massachusetts, United States

About

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Moderna raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsAlan R., Chief Procurement Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Moderna's next move

See what Strategic adds

Moderna raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.